docetaxel  (Thermo Fisher)

Journal: iScience

Article Title: 3D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments

doi: 10.1016/j.isci.2026.115865

Figure Lengend Snippet: PIM001-P PDX tumors persisted following conventional chemotherapy treatments (A) Schematic of the experimental approach used in the study. Images were adapted from BioRender. (B) Tumor volumes were monitored biweekly following the administration of chemotherapies to mice bearing orthotopic PIM001-P tumors ( n = 6 mice/group). Treatment groups were treatment-naïve (TN), Adriamycin + cyclophosphamide (AC), docetaxel + carboplatin (DTX+CRB), docetaxel (DTX), and carboplatin (CRB). Arrows at the top indicate when chemotherapy was administered. Asterisks above the x axis indicate early euthanasia due to animal health concerns. Residual tumors were harvested, as noted by arrows. Error bars represent the standard error of the mean. (C) Residual tumors were harvested, processed for FFPE, and analyzed by H&E staining and IHC for Ki67, Ku80, and human-specific mitochondria. Scale bars are 50 μm.

Article Snippet: Docetaxel , Hospira , Cat NO: 0409-0201-10; NDC: 0409-0201-10.

Techniques: Staining

Journal: iScience

Article Title: 3D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments

doi: 10.1016/j.isci.2026.115865

Figure Lengend Snippet: Single-agent chemotherapy treatments in PIM001-P significantly increased mitochondrial size in residual tumors relative to TN (A–E) Representative orthoslices. (a’-e’) Representative orthoslices with overlays of mitochondria segmentations. (a’’-e’’) Representative mitochondria segmentations for each treatment group: treatment-naïve (TN), adriamycin + cyclophosphamide (AC), docetaxel + carboplatin (DTX+CRB), docetaxel (DTX), and carboplatin (CRB). The scale bars are 3 μm. Mitochondrial measurements were calculated using Amira software for 350 segmented mitochondria (represented as dots) from each tumor for (f) 3D volume, (g) 3D area, (h), and perimeter. Adjusted p -values (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) are shown on box and whisker plots as determined using the Mann-Whitney U test followed by the Holm method.

Article Snippet: Docetaxel , Hospira , Cat NO: 0409-0201-10; NDC: 0409-0201-10.

Techniques: Software, Whisker Assay, MANN-WHITNEY

Journal: iScience

Article Title: 3D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments

doi: 10.1016/j.isci.2026.115865

Figure Lengend Snippet: Single-agent chemotherapy treated residual tumors’ mitochondria are more branched and less spherical relative to TN in PIM001-P (A) Representative longitudinal and transverse views of the segmented mitochondria for each treatment group: treatment-naïve (TN), adriamycin + cyclophosphamide (AC), docetaxel + carboplatin (DTX+CRB), docetaxel (DTX), and carboplatin (CRB). The scale bars are 3 μm. Mitochondrial measurements were calculated using Amira software for 350 segmented mitochondria (represented as dots) from each tumor for (B) sphericity (C) mitochondrial complex index (MCI), along with their respective method of measurements shown as a cartoon above the bar graphs. Adjusted p -values (∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001) are shown on box and whisker plots as determined using the Mann-Whitney U test followed by the Holm method.

Article Snippet: Docetaxel , Hospira , Cat NO: 0409-0201-10; NDC: 0409-0201-10.

Techniques: Software, Whisker Assay, MANN-WHITNEY

Journal: iScience

Article Title: 3D EM uncovers mitochondrial network remodeling in residual triple negative breast cancer after conventional chemotherapy treatments

doi: 10.1016/j.isci.2026.115865

Figure Lengend Snippet: The frequency of MLCs increases, while the sizes of the contacts decrease following chemotherapy Quantification of how chemotherapy remodels mitochondrial-lipid droplet contacts (MLCs) for each WHIM14 treatment group: treatment-naïve (TN), docetaxel + carboplatin (DTX+CRB), docetaxel (DTX), and carboplatin (CRB). (a-d’’) 3D rendering of the mitochondria in purple, lipid droplets in yellow, and their interaction in red. The scale bars are 2 μm. The 3D renders show that TN exhibits relatively few but broad, sheet-like interfaces, whereas all treatment groups display numerous, smaller, punctate contacts scattered across organelles. Consistent with this visual shift, bar plots demonstrate that the fraction of MLCs among the total number of segmented mitochondria (E; % MLC per 500 mitochondria) is higher after treatment. In contrast, per-contact surface area (F) and volume (G) are largest in TN and significantly reduced in all treated conditions, indicating that individual interfaces between the mitochondria and LDs shrink following chemotherapy. This is also displayed in the bar plots, showing the total sum of either surface area (H) or volume of the MLC versus the total sum of each metric for the segmented mitochondria.

Article Snippet: Docetaxel , Hospira , Cat NO: 0409-0201-10; NDC: 0409-0201-10.

Techniques:

Journal: Cancer Biology & Therapy

Article Title: Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis

doi: 10.1080/15384047.2026.2676474

Figure Lengend Snippet: Docetaxel triggers cuproptosis in breast cancer. (A) Western blotting method analyzing the expression of cuproptosis regulator FDX1 under varying concentrations of DTX with or without 1 µM CuCl 2 ( n = 3). (B) Western blotting method analyzing the expression of FDX1 under varying concentrations of DTX with or without 15 µM TTM ( n = 3). (C) IHC method analyzing the expression of FDX1 protein in clinical samples from breast cancer patients before and after DTX-based neoadjuvant chemotherapy ( n = 10). Scale bar: 200 μm. (D) AC008406.3 expression was measured by ISH experiments, and patients were stratified into high- and low-expression groups to compare DTX chemotherapy response rates ( n = 44). Scale bar: 200 μm. (E) ROC curve showing the predictive performance of AC008406.3 expression for chemotherapy response. (F) Determining the impact of AC008406.3 knockdown on the cytotoxic effects of DTX in breast cancer cells ( n = 4). * p < 0.05, ** p < 0.01, and *** p < 0.001.

Article Snippet: The reagents’ information is listed as follows: Elesclomol (ES; MedChem Express HY-12040), ML162 (MedChem Express HY-100002), Tetrathiomolybdate (TTM; Sigma-Aldrich 323446), Ferrostatin-1 (Fer-1; MedChem Express HY-100579), N -acetylcysteine (NAC; MedChem Express HY-B0215), Necrostatin-1 (Nec-1; MedChem Express HY-15760), Z-VAD-FMK (ZVF; MedChem Express HY-16658B), Dimethyl sulfoxide (DMSO; MedChem Express HY-Y0320), DTX (MedChem Express HY-B0011), Anhydrous copper (II) chloride (CuCl 2 ; Macklin 7447-39-4).

Techniques: Western Blot, Expressing, Knockdown